SCHEMBL1417879

SCHEMBL1417879

CCOC(=O)CCN(C)CCNC(=O)C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.58
ERBB2 P04626 7/20 0.56
KDR P35968 2/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
KDM4E B2RXH2 1/20 0.50
GAK O14976 1/20 0.50
MAPK13 O15264 1/20 0.50
ABL1 P00519 1/20 0.50
CYP1A2 P05177 1/20 0.50
CDK1 P06493 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417878 1.00 EGFR (0.58) EGFRERBB2KDRHDAC3HDAC4
SCHEMBL6505387 0.94 EGFR (0.58) EGFRERBB2KDRKDM4EGAK
SCHEMBL6505388 0.94 EGFR (0.58) EGFRERBB2KDRKDM4EGAK
SCHEMBL1419025 0.91 EGFR (0.62) EGFRERBB2KDRHDAC3HDAC4
SCHEMBL1419028 0.91 EGFR (0.62) EGFRERBB2KDRHDAC3HDAC4
SCHEMBL1417841 0.90 EGFR (0.60) EGFRERBB2
SCHEMBL6502203 0.90 EGFR (0.60) EGFRERBB2
SCHEMBL1418384 0.87 EGFR (0.61) EGFRERBB2KDRHDAC3HDAC4
SCHEMBL1418380 0.87 EGFR (0.61) EGFRERBB2KDRHDAC3HDAC4
SCHEMBL1417899 0.86 EGFR (0.63) EGFRERBB2KDRKDM4EGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298746-A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-03-23 EP disclosed
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed